Epistaxis Market: Product Innovation and Differentiation to Underscore Lucrative Growth Opportunities Through 2026

Posted on 2018-04-18 by Mark Hub in Healthcare // 0 Comments

Rockville, US, 2018-Apr-18 — /EPR Network/ — Exposure to harsh environment conditions and physical traumas has led to increasing instances of epistaxis. Growing instances of epistaxis or nose bleeding has further revved up demand for innovative medical devices for effective treatment purposes. In order to make improvements in therapeutics for patients with special medical conditions, leading manufacturers are concentrating on developing application-specific products. Through product innovation and differentiation, leading companies are focusing on gaining a competitive edge in the global market.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=344

With rapid advancements in technology, leading manufacturers are concentrating on incorporating innovative features in the epistaxis products. In order to improve experience of the customers, manufacturers are focusing on developing non-invasive products. In addition, manufacturers are concentrating on developing improved therapies and drugs, which helps in controlling constant nose bleeding. In order to expand their customer base, leading companies are offering medical products integrated with innovative technological features.

Nearly US$ 13 Mn Opportunity in Global Epistaxis Market

According to Fact.MR, the global epistaxis market is projected to reach a value of approximately US$ 13 Mn by 2026-end. Prevalence of chronic nosebleeds has led to surge in demand for epistaxis products globally. Attributed to extreme heat and dryness in the air, the level of moisture required in the nose can reduce. Extreme weather conditions such as dry winters and summers further leads to dry nasal membrane. Attributed to dry nasal membrane, occurrence of nosebleeds will continue to increase among individuals.

In order to offer effective treatment procedures, leading companies are focusing on offering epistaxis products equipped with advanced technological features. In addition, leading manufacturers are concentrating on developing non-surgical interventional treatment techniques. Some of the non-invasive techniques for the treatment of epistaxis include warm water irrigation and embolization. Other innovative treatment techniques for epistaxis include nasal cauterization, artery litigation, maxillary, and sphenopaletine artery. Leading manufacturers are also focusing on developing enhanced treatment techniques for patients with special medical disorders such as diabetes, asthma, cancer, and pregnancy. Through development of application-specific products, leading companies are focusing on attaining a competitive edge in the global market.

Browse Full Report with TOC @ https://www.factmr.com/report/344/epistaxis-market

Increasing instances of nosebleeds among adults and children has led to surge in demand for cauterization agents in the healthcare industry. In terms of revenue, cauterization agent products will continue to witness the highest growth in the global market by 2026-end. In contrary, antibiotic ointment products is projected to register the fastest growth in the global market throughout 2026.

Demand for epistaxis products will continue to remain concentrated for the treatment of anterior epistaxis. By 2026-end, anterior epistaxis is projected to generate significant revenues in the global market. However, posterior epistaxis indication will continue to reflect the fastest growth in the global market through 2026.

Sales of epistaxis products is projected to remain high through retail pharmacies. In terms of revenue, retail pharmacies is projected to represent a robust growth in the global market by 2017-end. On the other hand, sales in specialty clinics is projected to reflect the fastest growth in the global market throughout 2026.

Major market players in the global market are Ferring B.V., GlaxoSmithKline PLC, Smith & Nephew, Medline Industries, Inc., Pfizer Inc., Ciron Drugs & Pharmaceuticals Pvt. Ltd., and Bristol-Myers Squibb Company.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=344

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick